Orchestra Biomed Holdings, Inc. (OBIO)
7.25
+1.10
(+17.89%)
USD |
NASDAQ |
Nov 13, 16:00
7.18
-0.07
(-0.97%)
After-Hours: 19:59
Orchestra Biomed Holdings Enterprise Value : 428.14M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 428.14M |
| November 12, 2026 | 360.54M |
| November 11, 2026 | 351.93M |
| November 10, 2026 | 334.73M |
| November 09, 2026 | 332.88M |
| November 06, 2026 | 331.65M |
| November 05, 2026 | 327.97M |
| November 04, 2026 | 351.32M |
| November 03, 2026 | 324.28M |
| November 02, 2026 | 332.27M |
| October 30, 2026 | 345.79M |
| October 29, 2026 | 356.85M |
| October 28, 2026 | 350.70M |
| October 27, 2026 | 337.80M |
| October 26, 2026 | 323.67M |
| October 23, 2026 | 326.12M |
| October 22, 2026 | 318.75M |
| October 21, 2026 | 339.34M |
| October 20, 2026 | 340.26M |
| October 19, 2026 | 329.81M |
| October 16, 2026 | 317.52M |
| October 15, 2026 | 335.34M |
| October 14, 2026 | 329.20M |
| October 13, 2026 | 334.11M |
| October 12, 2026 | 345.79M |
| Date | Value |
|---|---|
| October 09, 2026 | 348.25M |
| October 08, 2026 | 334.73M |
| October 07, 2026 | 330.42M |
| October 06, 2026 | 341.49M |
| October 05, 2026 | 353.16M |
| October 02, 2026 | 348.25M |
| October 01, 2026 | 372.83M |
| September 30, 2026 | 364.84M |
| September 29, 2026 | 336.33M |
| September 28, 2026 | 324.91M |
| September 25, 2026 | 328.52M |
| September 24, 2026 | 328.52M |
| September 23, 2026 | 327.32M |
| September 22, 2026 | 344.75M |
| September 21, 2026 | 346.55M |
| September 18, 2026 | 336.33M |
| September 17, 2026 | 318.30M |
| September 16, 2026 | 332.12M |
| September 15, 2026 | 333.93M |
| September 14, 2026 | 325.51M |
| September 11, 2026 | 338.74M |
| September 10, 2026 | 320.10M |
| September 09, 2026 | 298.47M |
| September 08, 2026 | 297.26M |
| September 04, 2026 | 276.23M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 101.26M |
| Orthofix Medical, Inc. | 467.34M |
| ResMed, Inc. | 33.27B |
| Rockwell Medical, Inc. | 18.92M |
| Microbot Medical, Inc. | -1.771M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.75M |
| Revenue (Quarterly) | 0.091M |
| Total Expenses (Quarterly) | 18.84M |
| EPS Diluted (Quarterly) | -0.3036 |
| Gross Profit Margin (Quarterly) | -41.76% |
| Profit Margin (Quarterly) | -20.60K% |
| Earnings Yield | -12.49% |
| Normalized Earnings Yield | -12.70 |